newsfilter
← Latest News
PR Newswire·

Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Nuclear Regulatory Commission ("NRC") has issued its consent for the indirect...